AXLA — Axcella Health Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Avenue Therapeutics, Novocure, Danaher Corp, vTv Therapeutics
Axcella: Rises as FDA clears application for liver disease treatment study
Brief: Axcella Announces Axa1125’S Ind Clearance For The Treatment Of Nash
U.S. RESEARCH ROUNDUP- B&G Foods, Brandywine Realty Trust, Dollar General
Brief: Axcella Reports Fourth Quarter And Full Year 2020 Financial Results And Provides Business Update
Brief: Axcella Announces Ind Clearance For Axa1665, Program Updates And 2021 Milestones
Brief: Axcella Reports Q3 Loss Per Share $0.34
Brief: Axcella’S Late-Breaker Data From Axa1125-003 Clinical Study Presented At EASL Digital International Liver Congress
Brief: Results Of Axcella’S Axa1665-001 Clinical Study Published In Clinical And Translational Gastroenterology
Brief: Axcella Announces Patent Issuances Covering AXA1665
Brief: Axcella Health Says Entered Into Sales Agreement With SVB Leerink Relating To Shares Of Common Stock Offered By Prospectus
Brief: Axcella Health Files For $125 Million Mixed Shelf
Brief: Axcella Announces Pricing Of Public Offering Of Common Stock
Brief: Axcella Health Inc Files For Offering Of Up To 11.0 Mln Shares Of Common Stock
Brief: Axcella Reports Q1 Loss Per Share Of $0.65
Axcella Health: Surges on positive results for liver disease drugs
Brief: Axcella Announces Positive Top-Line Data From AXA1125-003 Clinical Study Showing Multifactorial Activity In Adult Subjects With NAFLD
Brief: Axcella Receives Fourth Patent Covering Emm Compositions
U.S. RESEARCH ROUNDUP-Liberty Oilfield Services, KB Home, Varex Imaging